
|Articles|September 20, 2019
Challenges and Barriers to 503B Compounding
Ernest P. Gates Jr., president, CEO, Gates Healthcare Associates, lays out some of the biggest hurdles to bulk compounding.
Advertisement
Ernest P. Gates Jr., president, CEO, Gates Healthcare Associates, lays out some of the biggest hurdles to bulk compounding.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Pharmacists Now Authorized to Independently Prescribe Buprenorphine
2
Bridging Barriers in Health Care Delivery to Push Pharmacy’s Path Forward
3
Diet and Insulin Management Technology Show Most Consistent Benefits for Type 1 Diabetes
4
Pharmacists Help Address Maternal Mortality With Drug Management | ASHP Midyear 2025
5



































































































































